1 completed, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Peritonitis: new trials by email Literature Review of Peritonitis trials Research Report on Peritonitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ZAVI APD ELF Protocol v2.2 Intravenous Infusion - Peritonitis, Pneumonia | Phase 1 | Unknown | Markus Zeitlinger | 20 | 2018-10-01 | 2021-09-08 |
| The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients Tissue Plasminogen Activator (tPA), recombinant deoxyribonuclease (DNase) - Peritoneal Dialysis, Peritoneal Dialysis, Continuous Ambulatory | Phase 1 | Terminated | Sir Charles Gairdner Hospital | 5 | 2016-01-01 | 2022-05-19 |
| Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels rhu-pGelsolin, Placebo - Low Gelsolin, Trauma | Phase 1 / Phase 2 | Completed | Critical Biologics Corporation | 40 | 2008-03-01 | 2010-09-29 |
Pneumonia (2) · Burns (1) · Infections (1) · Meretoja syndrome (1) · Sepsis (1) · Systemic Inflammatory Response Syndrome (1) · Wounds and Injuries (1)
Digestive System Diseases (3) · Intraabdominal Infections (3) · Peritoneal Diseases (3) · Infections (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Inflammation (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Shock (1)
Infusions, Intravenous (1) · Tissue Plasminogen Activator (1) · dornase alfa (1)
Critical Biologics Corporation (1) · Markus Zeitlinger (1) · Sir Charles Gairdner Hospital (1)
Australia (1) · Austria (1) · Hong Kong (1)
Aron Chakera, DPhil (1) · Richard C Straube, MD (1) · Selene Tam, PhD (1) · Wai M Chan, MBBS (1)